Clinical Trial Update: Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight [NA]

View source ↗

Summary

Ongoing randomized trial assesses the safety and efficacy of enteral vitamin D supplementation in extremely preterm infants (born <28 weeks or <1000 g).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin Deficiency

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Vitamin D Deficiency | NA | Status: RECRUITING